Simultaneous LC-MS/MS Analysis of the Plasma Concentrations of a Cocktail of 5 Cytochrome P450 Substrate Drugs and Their Metabolites-Reference-Cited by-同舟云学术

Simultaneous LC-MS/MS Analysis of the Plasma Concentrations of a Cocktail of 5 Cytochrome P450 Substrate Drugs and Their Metabolites

Published:2014 Issue:1 Volume:37 Page:18-25
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biol. Pharm. Bull.

Author:

Tanaka Shimako¹,Uchida Shinya¹,Inui Naoki²,Takeuchi Kazuhiko²,Watanabe Hiroshi²,Namiki Noriyuki¹

Affiliation:

1. Department of Pharmacy Practice & Science, School of Pharmaceutical Sciences, University of Shizuoka

2. Department of Clinical Pharmacology & Therapeutics, Hamamatsu University School of Medicine

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

https://www.jstage.jst.go.jp/article/bpb/37/1/37_b13-00401/_pdf

Reference14 articles.

1. 1) Michalets EL. Update: Clinically significant cytochrome P-450, drug interactions. Pharmacotherapy, 18, 84–112 (1998).

2. 2) Nebert DW, Russell DW. Clinical importance of the cytochromes P450. Lancet, 360, 1155–1162 (2002).

3. 3) Shimada T, Yamazaki H, Mimura M, Inui Y, Guengerich FP. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J. Pharmacol. Exp. Ther., 270, 414–423 (1994).

4. 4) Guengerich FP. Influence of nutrients and other dietary materials on cytochrome P-450 enzymes. Am. J. Clin. Nutr., 61 (Suppl.), 651S–658S (1995).

5. 5) Bebia Z, Buch SC, Wilson JW, Frye RF, Romkes M, Cecchetti A, Chaves-Gnecco D, Branch RA. Bioequivalence revisited: influence of age and sex on CYP enzymes. Clin. Pharmacol. Ther., 76, 618–627 (2004).

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytochrome P450 activity in rheumatoid arthritis patients during continuous IL-6 receptor antagonist therapy;European Journal of Clinical Pharmacology;2023-10-13

2. Initiation of glucose‐lowering drugs reduces the anticoagulant effect of warfarin—But not through altered drug metabolism in patients with type 2 diabetes;British Journal of Clinical Pharmacology;2023-04-14

3. Initiation of glucose-lowering drugs reduces the anticoagulant effect of warfarin – but not through altered drug metabolism in patients with type 2 diabetes;2022-10-11

4. A Method for Assay of Losartan, Its Active Metabolite E-3174, and Glibenclamide in Human Serum and Urine by HPLC-MS/MS;Pharmaceutical Chemistry Journal;2022-03-30

5. Pharmacokinetics of Caffeine: A Systematic Analysis of Reported Data for Application in Metabolic Phenotyping and Liver Function Testing;Frontiers in Pharmacology;2022-02-25